Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America

NCT05857397 is registered in ClinicalTrials.gov with Latin American Cooperative Oncology Group as lead sponsor.

NCT NCT05857397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05857397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America
Lead sponsor
Latin American Cooperative Oncology Group
Phase
Observational
Overall status
Active, not recruiting
Start date
July 21, 2023
Completion date
May 31, 2025
Enrollment
64 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer